Thymus Neoplasms
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases (NCT02859415) | National Cancer Institute (NCI) | 2019-08-08 |
| Study on Proton Radiotherapy of Thymic Malignancies (NCT04822077) | Ass. Prof. Jan Nyman | 2018-04-18 |
| Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma (NCT02364076) | Georgetown University | 2015-03-01 |
| Sunitinib for Advanced Thymus Cancer Following Earlier Treatment (NCT01621568) | National Cancer Institute (NCI) | 2012-05-15 |
| 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma (NCT01610544) | National Cancer Institute (NCI) | 2012-05-10 |
| Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies (NCT00921739) | Duke University | 2009-09-11 |
| Thoracic OncoGeriatric Assessment (TOGA) Trials (NCT00591981) | University of Wisconsin, Madison | 2007-08-01 |
Track Thymus Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.